IP Library Patent Application 19304173
Patent Application
App. No. 19/304,173

STENT GRAFTS WITH THERMAL PLEATING FOR ENHANCED FLEXIBILITY FOR TREATING ABDOMINAL AORTIC ANEURYSMS, INFRARENAL ABDOMINAL AORTIC ANEURYSMS, SUPRARENAL ABDOMINAL AORTIC ANEURYSMS, AND THORACIC AORTIC ANEURYSMS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/304,173
Abstract

A stent graft for surgical delivery in a target site of a patient to treat an aortic aneurysm. The stent graft includes a graft formed of graft material including a first portion to be received by a lower portion of an aorta that is relatively straight, and a second portion to be received by an upper portion of an aorta that is curved. The stent graft includes a stent attached to the graft including stent members. In a first orientation, the first and second portions of the graft material are folded between the stent members over first and second adjacent portions of the graft to form a first pleat and a second pleat. In a second orientation, the second pleat has a graft space between corresponding stent members on a greater curvature side of the stent graft that is greater than on a lesser curvature side of the stent graft.

Claims (38)

1 . A stent graft for surgical delivery in a target site of a patient to treat an aortic aneurysm, comprising:

a graft formed of graft material, the graft material comprising:

a first portion configured to be received by a lower portion of an aorta that is relatively straight, and

a second portion configured to be received by an upper portion of an aorta that is curved; and

a stent attached to the graft, the stent comprising stent members;

wherein:

in a first portion first orientation, the first portion of the graft material is folded between the stent members over a first adjacent portion of the graft to form a first pleat,

in a second portion first orientation, the second portion of the graft material is folded between the stent members over a second adjacent portion of the graft to form a second pleat, and

in a second portion second orientation, the second pleat has a graft space between corresponding stent members on a greater curvature side of the stent graft that is greater than on a lesser curvature side of the stent graft.

2 . The stent graft of claim 1 , wherein the second pleat is a partial pleat disposed on the lesser curvature side of the stent graft.

3 . The stent graft of claim 2 , wherein, in the second portion second orientation, the greater curvature side of the stent graft is free of the partial pleat.

4 . The stent graft of claim 1 , further comprising a drug eluting layer for eluting a bioactive agent from the stent graft after implantation.

5 . The stent graft of claim 1 , wherein the graft material comprises polytetrafluoroethylene (PTFE) or expanded PTFE (ePTFE).

6 . A stent graft for surgical delivery in a target site of a patient to treat an aortic aneurysm, comprising:

a graft formed of graft material; and

a stent attached to the graft, the stent comprising stent members;

wherein:

in a first orientation, the graft material is folded between the stent members over an adjacent portion of the graft to form a pleat, and

in a second orientation, the pleat has a graft space between corresponding stent members on a greater curvature side of the stent graft that is greater than on a lesser curvature side of the stent graft.

7 . The stent graft of claim 6 , wherein the pleat is a partial pleat disposed on the lesser curvature side of the stent graft.

8 . The stent graft of claim 7 , wherein, in the second orientation, the greater curvature side of the stent graft is free of the partial pleat.

9 . The stent graft of claim 6 , wherein the greater curvature side is opposite of the lesser curvature side.

10 . The stent graft of claim 6 , wherein the pleat is thermally set in the graft material.

11 . The stent graft of claim 6 , wherein the graft space is at least 4 millimeters.

12 . The stent graft of claim 6 , wherein, in the first orientation, the graft material is axially compressed.

13 . The stent graft of claim 6 , wherein, in the second orientation, the graft material is circularly compressed.

14 . The stent graft of claim 6 , wherein, in the first orientation, the graft material is folded abluminally with respect to a lumen of the stent graft.

15 . The stent graft of claim 6 , wherein, in the first orientation, the graft material is folded adluminally with respect to a lumen of the stent graft.

16 . The stent graft of claim 6 , wherein, in the first orientation, a first portion of the graft material is folded abluminally with respect to a lumen of the stent graft, and a second portion of the graft material is folded adluminally with respect to the lumen of the stent graft.

17 . The stent graft of claim 6 , further comprising a polymer layer for eluting a bioactive agent from the stent graft after implantation, the polymer layer comprising a drug eluting layer.

18 . The stent graft of claim 6 , wherein the graft material comprises polytetrafluoroethylene (PTFE) or expanded PTFE (ePTFE).

19 . A stent graft for surgical delivery in a target site of a patient to treat an aortic aneurysm, comprising:

a graft formed of graft material; and

a stent attached to the graft, the stent comprising stent members;

wherein:

in a first orientation, the graft material is folded between the stent members over an adjacent portion of the graft to form a partial pleat, and

in a second orientation, the graft material is circularly compressed and the partial pleat has a graft space between corresponding stent members on a greater curvature side of the stent graft that is greater than on a lesser curvature side of the stent graft, the greater curvature side of the stent graft being free of the partial pleat.

20 . The stent graft of claim 19 , further comprising drug eluting layer for eluting a bioactive agent from the stent graft after implantation, wherein the graft material comprises polytetrafluoroethylene (PTFE) or expanded PTFE (ePTFE).

Assignments (3)
SECURITY INTEREST Recorded Oct 10, 2025
From: ENDOLOGIX LLC
To: FIRST-CITIZENS BANK & TRUST COMPANY
Reel/Frame 072536/0612 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 19, 2025
From: EHNES, DALE
To: ENDOLOGIX, INC.
Reel/Frame 072062/0292 →
CHANGE OF NAME Recorded Aug 19, 2025
From: ENDOLOGIX, INC.
To: ENDOLOGIX LLC
Reel/Frame 072522/0810 →